January 26, 2013
BioMarin Seeks to Test Enzyme-Replacement Therapy in Batten Disease Patients
Read More
October 26, 2012
Alnylam Pharmaceuticals, BioMarin Pharmaceutical Inc.,and Cytonet Set to Speak on Conducting Effective Orphan Drug Research
Read More
X